Copertina

Featured Cover

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Erin R. Bonner, Werner Tschollar, Robert Anderson, Sulayman Mourabit
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation
di: Erin R. Bonner, et al.
Pubblicazione: (2025)

Featured Cover
di: Xingfei Pan, et al.
Pubblicazione: (2025)

Featured Cover
di: Kai Markus Schneider, et al.
Pubblicazione: (2025)

Featured Cover
di: Prateek Sharma, et al.
Pubblicazione: (2025)

Featured Cover
di: Tarek Hassanein, et al.
Pubblicazione: (2024)

Featured Cover
di: Shusuke Kumazaki, et al.
Pubblicazione: (2024)

Featured Cover
di: Nina Løn, et al.
Pubblicazione: (2024)

Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT‐UC Consortium
di: Parambir S. Dulai, et al.
Pubblicazione: (2024)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
di: Lukas Burghart, et al.
Pubblicazione: (2026)

Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening
di: Timothy McAuliffe, et al.
Pubblicazione: (2024)

Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
di: Ellen Werner, et al.
Pubblicazione: (2026)

Letter: Diet to Modify Risk of IBD—More Plants and Less Processed Food?
di: Alice S. Day, et al.
Pubblicazione: (2025)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
di: Dominik Bettinger, et al.
Pubblicazione: (2024)

Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?
di: Marlene Reincke, et al.
Pubblicazione: (2024)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
di: Louise J. M. Alferink, et al.
Pubblicazione: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
di: Michelle Spaan, et al.
Pubblicazione: (2025)

Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post‐operative recurrence of Crohn's disease
di: D. Bogatic, et al.
Pubblicazione: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
di: D. Bogatic, et al.
Pubblicazione: (2024)

Editorial: To Stop Or Not To Stop: Is It Still A Question?
di: Stephan R. Vavricka, et al.
Pubblicazione: (2024)

Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
di: Matthew K. W. Chu, et al.
Pubblicazione: (2025)

Editorial: Inflammation and Not Glucocorticoid Therapy is the Key Driver of Fracture Risk in IBD
di: Darcy Quinn Holt, et al.
Pubblicazione: (2024)

Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index (DASI) in predicting mortality and guiding prehabilitation. Authors' reply
di: Matthew J. Armstrong, et al.
Pubblicazione: (2024)

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
di: Lindsay M. Clarke, et al.
Pubblicazione: (2024)

Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK City
di: R. Parker, et al.
Pubblicazione: (2025)

Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
di: Uma Mahadevan, et al.
Pubblicazione: (2025)

Meta‐analysis: Intestinal ultrasound to evaluate colonic contents and constipation
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply
di: R. M. Mathias, et al.
Pubblicazione: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
di: Abhinav Vasudevan, et al.
Pubblicazione: (2024)

Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium
di: Ann T. Ma, et al.
Pubblicazione: (2024)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2025)

Letter on ‘Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas‐Sensing Wireless Motility Capsules’: Authors' Reply
di: Phoebe A. Thwaites, et al.
Pubblicazione: (2025)

Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003–2020
di: J. Couch, et al.
Pubblicazione: (2025)

Editorial: Ulcerative Colitis Management in the Biologic Era–Data From the English Healthcare Databases. Authors' Reply
di: J. Couch, et al.
Pubblicazione: (2025)

Letter: Dietary emulsifiers and intestinal health—The beginning of an evolving story: Authors’ reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
di: Peter R. Gibson, et al.
Pubblicazione: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2024)

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
di: Derek D. Satre, et al.
Pubblicazione: (2024)

Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD
di: Maria Ling Lundström, et al.
Pubblicazione: (2024)